 |
Neurogenetics, Inc. is a privately
held biopharmaceutical company dedicated to translating the
genetic discoveries concerning complex disorders of the human
brain into effective drugs. The company's major goals are to
discover and develop orally bio-available drugs for Alzheimer's
disease (AD) and related neurodegenerative disorders. |
